Skip to content
value.today
Amplifon S.p.A. logo

Amplifon S.p.A.

AMP.MI
$7.7 Blast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$2.7 B
For year ending December-2025
Net income
$103 M
3.8% margin
Official annual report (ESEF)
Employees
11,265
As on 2020
value.today research

Amplifon S.p.A. in brief

Amplifon S.p.A. is a listed company in the Medical Instruments industry, based in Italy. It was founded in 1950. Its last known market value was $7.7 B (January 2024); there is no current figure. In the year to December 2025 it had sales of $2.7 B and a net profit of $103 M, about 4 cents of profit for every dollar of sales. It employs about 11,265 people. Its shares trade under the symbol AMP.MI (Borsa Italiana).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Amplifon S.p.A.

Amplifon SpA is an Italian company based in Milan and the world's largest hearing aid retailer.

From Wikipedia: read the full article · text available under CC BY-SA 4.0

Amplifon S.p.A. timeline

3 events, 1950–2022
  1. 1950
  2. 🏁
    · approximate
    Founded by Algernon Charles Holland
  3. 2012
  4. •
    Legal Entity Identifier issued
    LEI ZYXJDNVM2JI3VBM8G556 registered.
  5. 2022
  6. 📊
    Market cap passed $10 billion
    $11.1 billion on 7 January 2022, from $9.3 billion on 1 January 2021.

Events of Amplifon S.p.A. from Wikidata, the GLEIF LEI register and our market-cap rankings. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$3.0 B$6.0 B$9.0 B$12.0 B20202021202220232024

World rank over time

▲ up 155 places since 2020
2020-01-01: #2221#2,22120202021-01-01: #1781#1,78120212022-01-07: #1722#1,72220222022-12-25: #2171#2,17120222023-07-30: #1911#1,91120232024-01-05: #2066#2,0662024

Rank in Italy: #24 (Jan 2020) · #21 (Jan 2021) · #16 (Jan 2022) · #24 (Dec 2022) · #20 (Jul 2023) · #23 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
—
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
3.8%
Operating margin
8.2%
Return on equity
8.8%
Liabilities / assets
74.4%
Revenue growth
+3.6%
Revenue per employee
$240 K
Profit per employee
$9 K

Financial history

USD · fiscal years · source: official annual reports (ESEF)
RevenueNet income
Fiscal year ending Dec 2024: revenue $2.6B, net income $157M$2.6BFY24Fiscal year ending Dec 2025: revenue $2.7B, net income $103M$2.7BFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$2.7B+3.6%$222M$103M3.8%
Dec 2024$2.6B—$278M$157M6.0%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$468M$64M$404M$0.45—
Dec 2024$488M$92M$396M$0.69—

Annual results

Revenue
$2.7 B
Operating income
$222 M
Net income
$103 M

For year ending December-2025 · source: official annual report (ESEF)

Balance sheet

Total assets
$4.6 B
Total liabilities
$3.4 B
Total equity
$1.2 B

As of December-2025

AMPLIFON SPA - Yearly Revenue and Net Income - in Million EUR

YearTotal Annual Revenue (EUR million)Gross Profit / Gross Operating Profit (EBITDA) (EUR million)Operating Profit / EBIT (EUR million)Net Income (EUR million)
20252,395.700511.600196.60091.300
20242,409.200561.100256.800145.400
20232,260.100526.800259.200155.100
20222,119.100518.700278.700178.500
20211,948.100468.300246.000157.800
20201,555.500371.000168.500101.000
20191,732.100370.600177.100108.700
20181,362.234225.467153.310100.443
20171,265.994212.491149.677100.578
20161,133.100186.900127.00063.600

AMPLIFON SPA - BALANCE SHEET SUMMARY- in Million EUR

YearTotal Assets (EUR mm)Total Liabilities (EUR mm)Total Equity (EUR mm)
20253,892.9162,894.391998.525
20243,992.7622,842.5381,150.224
20233,693.2152,591.5371,101.678
20223,575.4652,535.1151,040.350
20213,515.2912,588.010927.281
20203,228.4722,426.604801.868
20192,851.3382,155.223696.115
20182,255.5701,659.623595.947
20171,465.419877.001588.418
20161,405.963848.303557.660

Brands of Amplifon S.p.A. (2)#

Retail chain 2

Source: Wikidata. Brands whose Wikidata item names Amplifon S.p.A. (or a subsidiary of it) as owner, maker or parent organization; each brand's page links to its item

Mutual funds holding Amplifon S.p.A.#

63 funds in 2 countries hold shares worth $314 M. Since their previous reports 33 added shares and 22 sold, buying $21 M net. By country: USA 61 ($313 M), Sweden 2 ($1 M).
Mutual funds holding Amplifon S.p.A.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Goldman Sachs International Small Cap Insights FundGoldman Sachs Asset Management, L.P.3.47 M$49 M—0.68%+34%Jul 31, 2026
🇺🇸 T. Rowe Price International Discovery FundT. Rowe Price Associates, Inc.2.46 M$35 M—0.52%−2.6%Jul 31, 2026
🇺🇸 Oakmark International Small Cap FundHarris Associates L.P.2.73 M$30 M—2.5%−3.6%Jun 30, 2026
🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc.2.08 M$29 M—<0.01%+16%Jul 31, 2026
🇺🇸 SMALLCAP World Fund IncSMALLCAP World Fund Inc1.90 M$21 M—0.02%newJun 30, 2026
🇺🇸 Global X Artificial Intelligence & Technology ETFGlobal X Management Company LLC1.58 M$20 M—0.18%+4.1%May 31, 2026
🇺🇸 Vanguard Developed Markets Index FundThe Vanguard Group, Inc.1.38 M$15 M—<0.01%+19%Jun 30, 2026
🇺🇸 iShares Core MSCI EAFE ETFBlackRock Fund Advisors1.05 M$15 M—<0.01%+18%Jul 31, 2026
🇺🇸 AQR Long-Short Equity FundAQR CAPITAL MANAGEMENT, LLC1.35 M$15 M—0.19%−45%Jun 30, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC1.06 M$11 M—<0.01%+1.0%Jun 30, 2026
🇺🇸 iShares MSCI EAFE Small-Cap ETFBlackRock Fund Advisors545,692$8 M—0.06%+11%Jul 31, 2026
🇺🇸 Vanguard Ftse All-World Ex-Us Small-Cap Index FundThe Vanguard Group, Inc.543,047$8 M—0.06%+20%Jul 31, 2026
🇺🇸 Nuveen Quant International Small Cap Equity FundTeachers Advisors, LLC490,987$7 M—0.48%+1.7%Jul 31, 2026
🇺🇸 Bridge Builder International Equity FundOLIVE STREET INVESTMENT ADVISERS LLC548,217$6 M—0.02%+1.2%Jun 30, 2026
🇺🇸 Harbor International FundHarbor Capital Advisors, Inc.410,285$6 M—0.15%−2.7%Jul 31, 2026
🇺🇸 AQR Equity Market Neutral FundAQR CAPITAL MANAGEMENT, LLC518,989$6 M—0.20%−35%Jun 30, 2026
🇺🇸 Vanguard European Stock Index FundThe Vanguard Group, Inc.337,934$5 M—0.01%+17%Jul 31, 2026
🇺🇸 BlackRock Advantage International FundBlackRock Advisors, LLC336,449$4 M—0.05%+39%May 29, 2026
🇺🇸 International Core Equity 2 PortfolioDimensional Fund Advisors LP285,153$4 M—<0.01%no changeJul 31, 2026
🇺🇸 Schwab International Small-Cap Equity ETFCharles Schwab Investment Management, Inc.297,067$4 M—0.07%newMay 31, 2026
🇺🇸 iShares Core MSCI Total International Stock ETFBlackRock Fund Advisors178,835$3 M—<0.01%+1.3%Jul 31, 2026
🇺🇸 iShares Core MSCI International Developed Markets ETFBlackRock Fund Advisors166,021$2 M—<0.01%+4.6%Jul 31, 2026
🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc.115,553$2 M—<0.01%+30%Jul 31, 2026
🇺🇸 Fidelity Total International Index FundFidelity Management & Research Company LLC86,786$1 M—<0.01%+16%Jul 31, 2026
🇺🇸 Schwab Fundamental International Small Equity ETFCharles Schwab Investment Management, Inc.95,529$1 M—0.04%+20%May 31, 2026
🇺🇸 State Street SPDR Portfolio Developed World ex-US ETFSSGA Funds Management, Inc.95,484$1 M—<0.01%−0.1%Jun 30, 2026
🇺🇸 iShares Core MSCI Europe ETFBlackRock Fund Advisors72,748$1 M—0.01%+9.7%Jul 31, 2026
🇺🇸 Harbor Diversified International All Cap FundHarbor Capital Advisors, Inc.52,031$1 M—0.09%−8.0%Jul 31, 2026
🇺🇸 International Tilts Master PortfolioBlackRock Advisors, LLC63,377$1 M—0.07%−13%Jun 30, 2026
🇸🇪 Handelsbanken Global Småbolag Index CriteriaHandelsbanken Fonder AB60,829$1 M—0.02%+9.8%Jun 30, 2026
🇺🇸 Fidelity SAI International Small Cap Index FundFidelity Management & Research Company LLC44,660$1 M—0.06%+26%Jul 31, 2026
🇺🇸 International Equity FundGuideStone Capital Management, LLC57,429$1 M—0.05%−53%Jun 30, 2026
🇺🇸 SMALLCAP World FundCapital Research and Management Company51,829$1 M—0.02%newJun 30, 2026
🇺🇸 Schwab Fundamental International Small Equity Index FundCharles Schwab Investment Management, Inc.30,130$0 M—0.06%+32%Jul 31, 2026
🇺🇸 State Street Global All Cap Equity ex-U.S. Index PortfolioSSGA Funds Management, Inc.37,364$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Avantis International Equity ETFAmerican Century ETF Trust30,203$0 M—<0.01%+154%May 31, 2026
🇸🇪 Storebrand EuropaStorebrand Asset Management AS32,955$0 M—0.01%no changeJun 30, 2026
🇺🇸 International Vector Equity PortfolioDimensional Fund Advisors LP25,120$0 M—<0.01%no changeJul 31, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP24,895$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Esg International Stock ETFThe Vanguard Group, Inc.26,708$0 M—<0.01%+14%May 31, 2026
🇺🇸 SA Morgan Stanley International Equities PortfolioSunAmerica Asset Management, LLC21,685$0 M—0.09%newJul 31, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP21,326$0 M—<0.01%no changeJul 31, 2026
🇺🇸 AVIP BlackRock Advantage International Equity PortfolioCONSTELLATION INVESTMENTS INC26,553$0 M—0.08%+59%Jun 30, 2026
🇺🇸 AQR MS Fusion HV FundAQR CAPITAL MANAGEMENT, LLC23,371$0 M—0.36%+21%Jun 30, 2026
🇺🇸 iShares MSCI Europe Small-Cap ETFBlackRock Fund Advisors17,114$0 M—0.13%+18%Jul 31, 2026
🇺🇸 Invesco RAFI Developed Markets ex-U.S. Small-Mid ETFInvesco Capital Management LLC14,505$0 M—0.06%+17%Jul 31, 2026
🇺🇸 T. Rowe Price Global Allocation FundT. Rowe Price Associates, Inc.9,784$0 M—0.02%−2.8%Jul 31, 2026
🇺🇸 Dimensional VA International Small PortfolioDimensional Fund Advisors LP9,628$0 M—0.03%no changeJul 31, 2026
🇺🇸 International Social Core Equity PortfolioDimensional Fund Advisors LP8,586$0 M—<0.01%no changeJul 31, 2026
🇺🇸 BlackRock Multi-Asset Income PortfolioBlackRock Advisors, LLC8,516$0 M—<0.01%no changeJul 31, 2026
🇺🇸 International Sustainability Core 1 PortfolioDimensional Fund Advisors LP7,609$0 M—<0.01%no changeJul 31, 2026
🇺🇸 iShares MSCI World Small-Cap ETFBlackRock Fund Advisors7,043$0 M—0.01%−25%May 31, 2026
🇺🇸 LVIP Dimensional International Core Equity FundLincoln Financial Investments Corporation7,094$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Global Atlantic BlackRock Disciplined International Core PortfolioGlobal Atlantic Investment Advisors, LLC5,748$0 M—0.04%no changeJun 30, 2026
🇺🇸 State Street SPDR Portfolio Europe ETFSSGA Funds Management, Inc.5,593$0 M—<0.01%−2.3%Jun 30, 2026
🇺🇸 Brighthouse/Dimensional International Small Company PortfolioBrighthouse Investment Advisers, LLC4,705$0 M—0.01%no changeJun 30, 2026
🇺🇸 Avantis International Small Cap Equity ETFAmerican Century ETF Trust3,793$0 M—0.02%+18%May 31, 2026
🇺🇸 International Small Company TrustJohn Hancock Variable Trust Advisers LLC3,025$0 M—0.03%no changeJun 30, 2026
🇺🇸 AZL DFA International Core Equity FundAllianz Investment Management LLC2,889$0 M—0.01%no changeJun 30, 2026
🇺🇸 FlexShares Morningstar Developed Markets ex-US Factor Tilt Index FundNorthern Trust Investments, Inc.2,112$0 M—<0.01%−70%Jul 31, 2026
🇺🇸 BlackRock Dynamic High Income PortfolioBlackRock Advisors, LLC1,631$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Avantis Responsible International Equity ETFAmerican Century ETF Trust1,210$0 M—<0.01%+0.9%May 31, 2026
🇺🇸 Avantis International Equity FundAmerican Century ETF Trust1,006$0 M—<0.01%no changeMay 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 63 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Ownership and subsidiaries

Source: GLEIF
Amplifon S.p.A. directly owns 1 registered entity:

Amplifon S.p.A. scorecard#

Passes 3 of the 5 checks that could be worked out. Fiscal year 2025.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth1 of 2
    • ✓Revenue grew in the newest year3.6%Revenue up 3.6% in fiscal 2025.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • ✗Earnings per share grew in the newest year0.45 vs 0.69Diluted EPS 0.45 in fiscal 2025 against 0.69 the year before (report's currency).
    • –Net income higher than five years earlierNet income of five years earlier is not on file.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability2 of 3
    • ✓Profitable in the newest year$103 MNet income $103 M in fiscal 2025.
    • –Profitable in each of the last five yearsFive years of net income are not on file.
    • ✓Operating margin above its peers' median8.2%8.2% against Medical Instruments's median of 7.2% (46 companies).
    • ✗Return on equity above 15%8.7%8.7% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial healthnot known
    • –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (esef), the medians of Medical Instruments, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Amplifon S.p.A.'s statements, beside the median of Medical Instruments.

Amplifon S.p.A.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin8.2%7.2%
Net margin3.8%3.8%
Return on equity8.7%3.5%
Revenue growth3.6%8.9%
Free cash flow margin15.0%6.3%

3of 5on the Piotroski tests of financial strength

Amplifon S.p.A.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in EUR millions; per-share figures in EUR; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Amplifon S.p.A.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021
Income statement
Revenue2,3962,4092,2602,1191,948
Total costs and expenses1,8821,8551,7421,6101,485
Operating income197257259279246
Income before tax132197210244223
Income tax4051556560
Income from continuing operations——155179164
Income from discontinued operations———0−5.8
Net income including minority interests92146155179158
Minority interests' share of net income0.20.2−0.10.30.1
Net income attributable to shareholders91145155179158
Earnings per share, basic0.410.640.690.800.70
Earnings per share, diluted0.400.640.690.790.69
Balance sheet
Cash and cash equivalents309289193180269
Receivables222227231192169
Inventory8293887663
Current assets763725621593647
Property, plant and equipment237254222193187
Right-of-use (leased) assets462492478452437
Goodwill1,9271,9451,8001,7541,681
Other intangible assets381428417420415
Investments in associates0.02.52.42.12.1
Non-current assets3,1303,2683,0722,9832,869
Total assets3,8933,9933,6933,5753,515
Current liabilities1,2561,1701,1791,056886
Lease liabilities (non-current)364388384369353
Non-current liabilities1,6381,6721,4121,4791,702
Shareholders' equity9981,1501,1011,039925
Minority interests0.30.20.81.82.1
Total equity9991,1501,1021,040927
Total liabilities and equity3,8933,9933,6933,5753,515
Cash-flow statement
Cash from operating activities415451414459462
Capital expenditure−56−85−75−57−52
Intangible assets bought−62−61−66−59−62
Acquisitions, net of cash acquired−62−193−108−85−420
Cash from investing activities−187−335−261−194−534
Debt issued109199−0.0−1287.9
Debt repaid−0.0−0.8−50−0.1−41
Shares bought back−108−250−53−31
Dividends paid−65−66−65−58−49
Cash from financing activities−202−19−135−354−209
Exchange-rate effect on cash−5.2−1.5−3.50.13.4
ReportESEFESEFESEFESEFESEF

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: ESEF annual reports (filings.xbrl.org) · as of Dec 31, 2025. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Where Amplifon S.p.A. operates: 2 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 1 subsidiaries on file.

Present: offices, subsidiaries, branches or revenue (2 countries)Nothing on fileDots mark countries too small to see. Hover, tap or tab to a country for its figures.
Amplifon S.p.A.: countries of operation
CountryPresenceRevenue there
🇮🇹 ItalyHeadquarters2 offices—
🇧🇪 Belgium1 subsidiary—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Lobbying by Amplifon S.p.A.#

$200 K spent on lobbying the US Congress and federal agencies in 2025, most often on budget/appropriations, health issues and medicare/medicaid.

Lobbying, 2025
$200 K
#962 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2025
2026 so far
$150 K
  • Budget/Appropriations4 reports
  • Health Issues4 reports
  • Medicare/Medicaid4 reports

Lobbying firms hired in 2025

Thorn Run Partners $200 K

Amplifon S.p.A.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2026 (so far)$150 K—3
2025$200 K—4
2024$200 K—4
2023$200 K—4
2022$280 K—4
2021$270 K—7
2020$210 K—4
2019$240 K—4
2018$230 K—3

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Amplifon USA”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

H-1B hiring at Amplifon S.p.A.#

2 labor condition applications certified in fiscal 2026 for 2 positions, at a median wage of $125 K a year.

Certified, FY2026
2
#1,433 among companies on value.today
Worker positions
2
Median wage offered
$125 K
a year, full-time
Applications filed
2
Amplifon S.p.A.: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
Senior Business Intelligence SpecialistBusiness Intelligence Analysts2$125 K

Where: Melissa, TX 2

Amplifon S.p.A.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202622$125 K2
FY202544$95 K5
FY202433$280 K3
FY202322$128 K2
FY202211$135 K1
FY202111$85 K1
FY202022$98 K2

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Amplifon (USA), Inc.

How Amplifon S.p.A. compares in Medical Instruments

  • Revenue$2.7 B · higher than 81% of 120
  • Net margin3.8% · higher than 31% of 114
  • Revenue growth3.6% · higher than 25% of 49

Peer comparison · Medical Instruments

CompanyMarket capP/ENet marginRev. growth
Amplifon S.p.A.🇮🇹$7.7 B—3.8%+3.6%
Intuitive Surgical, Inc.🇺🇸$155.6 B52.6×25.5%+20.5%
EssilorLuxottica S.A.🇫🇷$88.0 B32.1×8.1%+4.5%
HOYA Corporation🇯🇵$56.2 B32.8×25.4%—
Becton, Dickinson and Company🇺🇸$54.0 B57.4×4.2%+8.2%
Alcon Inc.🇨🇭$37.1 B37.9×9.4%+4.9%
ResMed Inc.🇺🇸$35.3 B22.1×27.8%+9.8%
West Pharmaceutical Services, Inc.🇺🇸$27.1 B42.4×18.8%+6.3%
Terumo Corporation🇯🇵$24.9 B27.0×12.0%—

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As on 2020
Profile updated:
Nov 4, 2026

Figures from Official annual report (ESEF), value.today research, Wikipedia, Wikimedia Commons, Wikidata, GLEIF register.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Amplifon S.p.A.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Amplifon S.p.A.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Amplifon S.p.A.? Suggest a correction